Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01099358
Title Study in Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

Advanced Solid Tumor

Therapies

Cetuximab + Cisplatin

Fluorouracil

Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
University of Kansas Medical Center Fairway Kansas 66205 United States Details
VA Sierra Nevada Health Care System Reno Nevada 89502 United States Details
University of North Carolina Chapel Hill North Carolina 27599 United States Details
University of Texas Health Science Center - San Antonio San Antonio Texas 78229 United States Details
For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. London N6A 4L6 Canada Details
For additional information regarding investigative sites for this trial, contact 1-888-545-5972 Mon - Fri, 9 AM to 4 PM or 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time or speak with your personal physician. Toronto M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field